A new utilisation report is available to CCGs aimed at helping identify barriers to using GP2GP. The GP2GP team produce a monthly CCG GP2GP utilisation report showing all practices within England (live and not live with GP2GP) and detailed information to enable CCGs (and where designated, CSUs), to fully understand the utilisation of GP2GP within each region. Guidance and frequently asked questions are included in the report to help users better understand common queries, possible issues and scenarios. This report includes full details of each practice’s GP2GP requesting, sending and integration activity which should help identify potential barriers to using GP2GP. The new report will be emailed between the 10th and 15th of every month to subscribers.
Parkinson’s Awareness Week 2015 takes place 20-26 April 2015. The theme of the campaign ‘Up Your Friendly’ is encouraging people to be friendlier to people with Parkinson’s. Simply by holding a door open or being more patience in a long queue can brighten up someone’s day. But for people with Parkinson’s, it can make all the difference. Parkinson’s UK has free resources available support the week event.
The Royal Society for Public Health and Public Health England has published Healthy Conversations and the Allied Health Professionals. This report illustrates that allied health professionals are having a significant positive impact on the public’s health and with further support this could make a real difference to the health and wellbeing of the population.
As part of its savings and productivity collection, NICE has published Tobacco return on investment tool. The tool has been developed to help decision making in tobacco control at local and sub-national levels. It evaluates a portfolio of tobacco control interventions and models the economic returns that can be expected in different payback timescales. Different interventions, including pharmacotherapies and support and advice, can be mixed and matched to see which intervention portfolio or package provides the best ‘value for money’, compared with ‘no-services’ or any other specified package.
Here’s what they found:
- Omega 3 supplementation for periods up to five years did not slow progression to advanced AMD or reduce significant visual loss compared to a placebo.
- The incidence of adverse effects (gastrointestinal disorders, bad breath and allergic dermatitis) was similar in the omega 3 and placebo groups
- There was no evidence on the use of omega 3 supplements to prevent AMD
How good was the evidence?
The evidence on the rate of progression of AMD was high quality and for the other outcomes it was moderate quality.
Where does this leave us?
There is no evidence from RCTs to support increasing omega 3 intake in order to prevent or slow AMD.
Important things we still don’t know:
- Whether omega 3 supplementation prevents AMD
- Whether the effects of taking omega 3 supplements is different in different populations (does ethnicity, nutritional status, or the stage of AMD make a difference, for example?)
- Whether the composition or source (such as oily fish versus fish oil supplements) of the omega 3 makes a difference
There has been a great deal of research into the potential health benefits of omega 3, including a number of Cochrane reviews, and most often the conclusions reached are that more research is needed. The authors of this review suggest that a cost-effective approach would be to include AMD outcomes in large trials of other diseases and they found one that is currently ongoing.
Let’s hope that future updates of this review will be able to draw on more high quality evidence to help answer some of the remaining questions.
Lawrenson JG, Evans JR. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration.Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD010015. DOI: 10.1002/14651858.CD010015.pub3.
In 2013 the NHS Citizen project team was commissioned to develop a blueprint for how citizens can play a more active role in NHS England’s decision making future. As a result the team has produced the NHS Citizen design. The design consists of two main parts: tools and processes to give citizens a more powerful voice in NHS decision-making and enable citizens to hold the board of NHS England to account; and an investigation of what this means both for the NHS and for citizens.
Additional link: NHS England press release
The BMA has published National survey of GPs: The future of General Practice 2015. The questions contained in this survey examine GPs’ priorities and views on the future of general practice. The questions cover essentials of general practice, premises, general practice models, future of GP contracts, career motivations, workload, consultation times, access and opening hours and technology.